Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Multicenter collaborative panic disorder severity scale

M K Shear1, T A Brown, D H Barlow

  • 1Department of Psychiatry, University of Pittsburgh, PA, USA. shearmk@msx.upmc.edu

The American Journal of Psychiatry
|November 14, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effectiveness of the Unified Protocol for transdiagnostic treatment of emotional disorders in group format in Spain: Results from a randomized controlled trial with 6-months follow-up.

Psychotherapy research : journal of the Society for Psychotherapy Research·2021
Same author

Individualized vaginal bleeding experience of women with uterine fibroids in the PEARL I randomized controlled trial comparing the effects of ulipristal acetate or placebo.

Human reproduction (Oxford, England)·2014
Same author

A comparison of alprazolam and behavior therapy in treatment of panic disorder.

The Journal of psychotherapy practice and research·2012
Same author

Effect of oestradiol treatment on 5-HT and dopamine-mediated neuroendocrine responses.

Journal of psychopharmacology (Oxford, England)·2012
Same author

Towards a new integration of psychology and pharmacology.

Journal of psychopharmacology (Oxford, England)·2012
Same author

Mind the gap: Improving the dissemination of CBT.

Behaviour research and therapy·2009
Same journal

2026 Annual Meeting: President-Elect Address.

The American journal of psychiatry·2026
Same journal

2026 Annual Meeting: CEO and Medical Director's Address.

The American journal of psychiatry·2026
Same journal

Reports to the Membership.

The American journal of psychiatry·2026
Same journal

Convergent Metabolic Dysregulations But Divergent Contributing Pathways Across Severe Mental Disorders: The Power of Combining Genetics and Metabolomics.

The American journal of psychiatry·2026
Same journal

2026 Annual Meeting: Presidential Address.

The American journal of psychiatry·2026
Same journal

Represcribing Previously Used Antipsychotics: Response to So.

The American journal of psychiatry·2026
See all related articles

The Panic Disorder Severity Scale offers a simple, reliable tool for assessing panic disorder severity in clinical settings. This validated scale demonstrates good reliability and sensitivity for measuring panic disorder symptoms.

Area of Science:

  • Psychiatry
  • Clinical Psychology
  • Psychometric Assessment

Background:

  • Lack of a standardized instrument for assessing panic disorder severity.
  • Need for a simple and efficient clinical rating scale.

Purpose of the Study:

  • To develop and validate the Panic Disorder Severity Scale (PDSS).
  • To provide a reliable measure for overall panic disorder severity.

Main Methods:

  • The seven-item PDSS was used by 10 evaluators on 186 panic disorder patients.
  • Assessed interrater reliability, internal consistency, validity, and sensitivity to change.
  • Included reevaluations after short-term treatment and independent assessments.

Main Results:

Related Experiment Videos

  • The PDSS demonstrated excellent interrater reliability.
  • Moderate internal consistency and favorable validity and sensitivity to change were observed.
  • Individual items showed good convergent and discriminant validity; a two-factor model fit the data.

    • Conclusions:

    • The PDSS is a simple and efficient tool for clinicians to rate severity in panic disorder patients.
    • Further research is needed with diverse patient groups and broader validity measures.